| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $46.26M | $42.38M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $16.51M | $16.65M | $19.48M | $17.02M | $17.52M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$33.09M | $28.44M | -$465.00K | -$7.59M | $56.86M |
| EPS (basic) | -2.4700 | 1.2500 | 1.5000 | 1.3700 | 1.0000 |
| EPS (diluted) | -2.4700 | 1.2500 | 1.5000 | 1.3700 | 1.0000 |
| Shares (diluted) | $13.40M | $13.40M | $13.40M | $13.42M | $13.41M |